Stay ahead of every
FDA & EMA decision.
Monthly briefings for BD teams, investors, CROs/CMOs and regulatory consultants — covering what moves pipelines, deals and markets across FDA, EMA and APAC.
What you'll receive each month
Curated for industry professionals — not patient-facing content. Every edition focuses on regulatory catalysts, pipeline milestones and deal flow.
- PDUFA Date Alerts
Know every FDA decision deadline before it moves markets.
- FDA & EMA Regulatory Updates
Approvals, rejections, complete response letters, advisory committee outcomes.
- Pipeline Intelligence
Phase III readouts, NDA/BLA filings, orphan drug designations, breakthrough therapy.
- BD & Licensing Deals
Partnerships, licensing agreements, M&A signals — with deal value when disclosed.
- Market-Moving Data
Clinical trial results, comparative efficacy, commercial launch milestones.
- Multi-Region Coverage
US (FDA), EU (EMA), and APAC (PMDA, NMPA, TGA) in one briefing.
Get the briefing
Free. No commitment. Cancel any time.
Check your inbox for the welcome email.